|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 453.40 INR | +4.86% |
|
+1.75% | +2.73% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 219M 192M 177M 165M 311M 318M 2.13B 821M 10.2B 821M 803M 35.42B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 258M 226M 208M 195M 366M 375M 2.51B 968M 12.03B 969M 947M 41.76B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.86% | ||
| 1 week | +1.75% | ||
| Current month | +29.52% | ||
| 1 month | +28.24% | ||
| 3 months | +59.76% | ||
| 6 months | +1.99% | ||
| Current year | +2.73% |
| 1 week | 424.6 |  | 465 |
| 1 month | 339 | | 515.55 |
| Current year | 280 | | 515.55 |
| 1 year | 280 | | 656.85 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.86% | +1.75% | -23.48% | +22.14% | 323M | |
| +0.62% | +10.52% | +56.25% | +162.23% | 1,077B | |
| +0.86% | +10.79% | +67.75% | +56.15% | 613B | |
| +0.19% | +10.52% | +36.95% | +90.81% | 448B | |
| +1.86% | +4.85% | +28.17% | +22.04% | 332B | |
| -0.14% | +7.58% | +41.28% | +27.25% | 293B | |
| -0.06% | +4.92% | +31.23% | +41.59% | 286B | |
| -0.96% | +4.98% | -28.37% | -40.96% | 215B | |
| +0.24% | +4.35% | +28.84% | +62.66% | 193B | |
| -1.45% | +0.87% | +13.61% | +65.71% | 159B | |
| Average | +0.62% | +7.27% | +25.22% | +50.96% | 361.64B | |
| Weighted average by Cap. | +0.41% | +9.65% | +41.67% | +80.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 180M 158M 146M 136M 256M 262M 1.75B 677M 8.41B 677M 662M 29.2B | 21.11B 223M 196M 180M 169M 317M 324M 2.17B 838M 10.41B 839M 820M 36.16B |
| Net income | -705M -7.45M -6.53M -6.03M -5.63M -10.59M -10.83M -72.51M -27.99M -348M -27.99M -27.38M -1.21B | 1.38B 14.55M 12.74M 11.76M 10.98M 20.67M 21.14M 141M 54.62M 678M 54.62M 53.43M 2.36B |
| Net Debt | 953M 10.08M 8.82M 8.14M 7.61M 14.32M 14.64M 98.01M 37.84M 470M 37.84M 37.01M 1.63B | 3.7B 39.16M 34.28M 31.65M 29.56M 55.64M 56.9M 381M 147M 1.83B 147M 144M 6.34B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | ₹453.40 | +4.86% | 20,985 |
| 25/06/26 | ₹432.40 | -0.08% | 4,025 |
| 24/06/26 | ₹432.75 | -0.75% | 1,609 |
| 23/06/26 | ₹436.00 | -2.69% | 7,352 |
| 22/06/26 | ₹448.05 | +0.55% | 3,140 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
